| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/12/2002 | EP1212447A1 Selection for more efficient transformation host cells |
| 06/12/2002 | EP1212446A2 Viral replicons and viruses dependent on inducing agents |
| 06/12/2002 | EP1212445A2 Transcriptionally silenced plant genes |
| 06/12/2002 | EP1212444A1 Dna construct and its use |
| 06/12/2002 | EP1212443A2 Targeted gene removal |
| 06/12/2002 | EP1212442A2 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 06/12/2002 | EP1212441A2 Plant regulatory sequences for control of gene expression |
| 06/12/2002 | EP1212440A2 Plants having reduced activity in two or more starch-modifying enzymes |
| 06/12/2002 | EP1212439A1 Plants having altered amino acid contents and method for the production thereof |
| 06/12/2002 | EP1212438A1 Flax seed specific promoters |
| 06/12/2002 | EP1212437A2 Method for genetic modification of lactobacillus delbrueckii |
| 06/12/2002 | EP1212436A2 Protein phosphatase and kinase proteins |
| 06/12/2002 | EP1212434A2 Human hydrolytic enzymes |
| 06/12/2002 | EP1212433A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 06/12/2002 | EP1212432A1 Methods for purifiying dna polymerases |
| 06/12/2002 | EP1212431A2 Phosphomevalonate kinase (pmk) gene (erg8) from candida albicans |
| 06/12/2002 | EP1212430A1 Nuclease variant and their use in genotyping assays |
| 06/12/2002 | EP1212429A2 Luciferase expression cassettes and methods of use |
| 06/12/2002 | EP1212428A1 Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression |
| 06/12/2002 | EP1212427A2 Basb128 polypeptide and polynucleotide fron moraxella catarrhalis |
| 06/12/2002 | EP1212426A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 06/12/2002 | EP1212425A2 Phage resistant streptococcus thermophilus |
| 06/12/2002 | EP1212424A2 Moraxella catarrhalis antigen basb125 |
| 06/12/2002 | EP1212423A2 Identification of the domain of plasmodium falciparum erythrocyte membrane protein 1 (pfemp1) that mediates adhesion to chondroitin sulfate a |
| 06/12/2002 | EP1212422A2 Human ctla-4 antibodies and their uses |
| 06/12/2002 | EP1212421A1 Gas1 polypeptides |
| 06/12/2002 | EP1212420A1 Conditional immortalisation of cells |
| 06/12/2002 | EP1212419A2 Polycyclic aromatic hydrocarbon induced molecules |
| 06/12/2002 | EP1212418A2 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 06/12/2002 | EP1212417A2 Interleukin-1-receptor associated kinase-3 (irak3) |
| 06/12/2002 | EP1212416A2 Nucleic acid based modulators of gene expression |
| 06/12/2002 | EP1212415A1 Pgrp-l polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212413A1 A transmembrane trap for isolating membrane bound proteins |
| 06/12/2002 | EP1212412A2 Nucleic acids which code for the enzyme activities of the spinosyn biosynthesis |
| 06/12/2002 | EP1212411A2 Methods and compositions for the construction and use of fusion libraries |
| 06/12/2002 | EP1212410A2 Dna encoding the human serine protease eos |
| 06/12/2002 | EP1212409A2 Alkaline bacillus amylase |
| 06/12/2002 | EP1212408A2 Bryostatins, bryopyrans and polyketides: compositions and methods |
| 06/12/2002 | EP1212407A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212406A1 Cell-free assay for plant gene targeting and conversion |
| 06/12/2002 | EP1212404A2 Isolation of muscle-derived stem cells and uses therefore |
| 06/12/2002 | EP1212366A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
| 06/12/2002 | EP1212364A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 06/12/2002 | EP1212363A2 Il-16 antagonists |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212360A2 Nucleotide sequences derived from genes coding for trimethylamine n-oxide reductase, uses thereof in particular for detecting bacteria |
| 06/12/2002 | EP1212359A1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
| 06/12/2002 | EP1212358A2 Synthetic papillomavirus genes optimized for expression in human cells |
| 06/12/2002 | EP1212357A1 Crystal structure of a deacetylase and inhibitors thereof |
| 06/12/2002 | EP1212355A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 06/12/2002 | EP1212349A1 Recombinant subunit vaccine |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212343A1 52 human secreted proteins |
| 06/12/2002 | EP1212342A2 18 human secreted proteins |
| 06/12/2002 | EP1212341A1 Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase |
| 06/12/2002 | EP1212340A1 29 human cancer associated proteins |
| 06/12/2002 | EP1212339A1 2'-o-acetamido modified monomers and oligomers |
| 06/12/2002 | EP1212331A1 28-epirapalogs |
| 06/12/2002 | EP1212137A1 Analytical test device with substrate having oriented through going channels and improved methods and apparatus for using same |
| 06/12/2002 | EP1212133A1 Method and device for applying a plurality of microdroplets onto a substrate |
| 06/12/2002 | EP1212100A2 Delivery system for antidandruff agent |
| 06/12/2002 | EP1212096A2 Drug conjugates and methods of designing the same |
| 06/12/2002 | EP1212084A2 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 06/12/2002 | EP1212083A1 Oral recombinant lactobacilli vaccines |
| 06/12/2002 | EP1212082A1 Monoclonal antibodies and antibody cocktail for detection of prion protein as an indication of transmissible spongiform encephalopathies |
| 06/12/2002 | EP1211933A1 Pa28 modified transgenic mice |
| 06/12/2002 | EP1211932A2 A method of transgenic fowl construction |
| 06/12/2002 | EP1211931A1 A knockout mouse for the tumor suppressor gene anx7 |
| 06/12/2002 | EP1092042A4 Method to determine predisposition to hypertension |
| 06/12/2002 | EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 06/12/2002 | EP1005477B1 Method for isolating anionic organic substances from aqueous systems using cationic polymer nanoparticles |
| 06/12/2002 | EP0999738A4 Transgenic seedless fruit and methods |
| 06/12/2002 | EP0983364B1 Dna polymerases having improved labeled nucleotide incorporation properties |
| 06/12/2002 | EP0946752B1 Method of sequencing dna based on the detection of the release of pyrophosphate |
| 06/12/2002 | EP0932697B1 Method for prediction of progression of normal and hyperplastic mammary cells to carcinoma |
| 06/12/2002 | EP0861334B1 Method of quantifying tumour cells in a body fluid and a suitable test kit |
| 06/12/2002 | EP0856064B1 Soybean peroxidase electrochemical sensor |
| 06/12/2002 | EP0832212A4 Intergenic regions of banana bunchy top virus |
| 06/12/2002 | EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules |
| 06/12/2002 | EP0777677B1 Methods of identifying compounds useful for treating autoimmune diseases |
| 06/12/2002 | EP0759472B1 Process for producing trans-4-hydroxy-l-proline |
| 06/12/2002 | EP0749317B1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 06/12/2002 | EP0741576B1 Co-administration of interleukin-3 mutants with colony stimulating factors |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | EP0722452B1 Nf-at polypeptides and polynucleotides |
| 06/12/2002 | EP0695367A4 Ligase chain reaction with endonuclease iv correction and contamination control |
| 06/12/2002 | EP0673429B1 Production of heterologous proteins in filamentous fungi |
| 06/12/2002 | EP0574395B1 Cytokine immunoconjugates |
| 06/12/2002 | EP0433372B1 Oral immunization by transgenic plants |
| 06/12/2002 | CN1353769A In vivo selection method for determining inhibitory RNA molecules |
| 06/12/2002 | CN1353764A Method for selecting improved vectors |
| 06/12/2002 | CN1353763A Chimeric expression promoters originating from commelina yellow mottle virus and cassava vein mosaic virus |
| 06/12/2002 | CN1353762A Pectate lyase fusion for expression and secretion of polypeptides |
| 06/12/2002 | CN1353761A Preparation of biologically active molecules |
| 06/12/2002 | CN1353760A Nucleic acid sequences to proteins involved in isoprenoid synthesis |
| 06/12/2002 | CN1353759A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 06/12/2002 | CN1353758A Process for fermentative preparation of 1-amino acids with amplification of ZWF gene |
| 06/12/2002 | CN1353757A Microbiological production method for 2-L-aspartyl-L-phenylalanine |
| 06/12/2002 | CN1353756A Compositions and method for the modification of gene expression |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |